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A B S T R A C T
Nigeria has the heaviest burden of lymphatic ﬁlariasis (LF) in sub-Saharan Africa, which is caused
by the parasite Wuchereria bancrofti and transmitted by Anopheles mosquitoes. LF is targeted for
elimination and the national programme is scaling up mass drug administration (MDA) across the
country to interrupt transmission. However, in some regions the co-endemicity of the ﬁlarial
parasite Loa loa (loiasis) is an impediment due to the risk of severe adverse events (SAEs) as-
sociated with the drug ivermectin. To better understand factors inﬂuencing LF elimination in
loiasis areas, this study conducted a cross-sectional survey on the prevalence and co-distribution
of the two infections, and the potential demographic, landscape, human movement, and inter-
vention-related risk factors at a micro-level in the South West zone of Nigeria. In total, 870
participants from 10 communities on the fringe of a meso-endemic loiasis area of Osun State were
selected. LF prevalence was measured by clinical assessment and using the rapid im-
munochromatographic test (ICT) to detect W. bancrofti antigen. Overall LF prevalence was low
with ICT positivity ranging from 0 to 4.7%, with only 1 hydrocoele case identiﬁed. Males had
signiﬁcantly higher ICT positivity than females (3.2% vs 0.8%). Participants who did not sleep
under a bed net had higher ICT positivity (4.0%) than those who did (1.3%). ICT positivity was
also higher in communities with less tree coverage/canopy height (2.5–2.8%) than more forested
areas with greater tree coverage/canopy height (0.9–1.0%). In comparison, loiasis was de-
termined using the rapid assessment procedure for loiasis (RAPLOA), and found in all 10 com-
munities with prevalence ranging from 1.4% to 11.2%. No signiﬁcant diﬀerence was found by
participants' age or sex. However, communities with predominately shrub land (10.4%) or
forested land cover (6.2%) had higher prevalence than those with mosaic vegetation/croplands
(2.5%). Satellite imagery showed denser forested areas in higher loiasis prevalence communities,
and where low or no ICT positivity was found. Only one individual was found to be co-infected.
GPS tracking of loiasis positive cases and controls also highlighted denser forested areas within
higher loiasis risk communities and the sparser land cover in lower-risk communities. Mapping
LF-loiasis distributions against landscape characteristics helped to highlight the micro-
https://doi.org/10.1016/j.parepi.2017.12.001
Received 2 October 2017; Received in revised form 20 December 2017; Accepted 26 December 2017
⁎ Corresponding author.
1 Dual ﬁrst authors.
E-mail address: Louise.Kelly-Hope@lstmed.ac.uk (L.A. Kelly-Hope).
Parasite Epidemiology and Control 3 (2018) 21–35
Available online 28 December 2017
2405-6731/ © 2017 Published by Elsevier Ltd on behalf of World Federation of Parasitologists. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
heterogeneity, identify potential SAE hotspots, and determine the safest and most appropriate
treatment strategy.
1. Introduction
Lymphatic ﬁlariasis (LF) is a mosquito-borne parasitic neglected tropical disease (NTD) targeted for global elimination by the year
2020 as part of the Global Programme to Eliminate LF (GPELF) (World Health Organization, 2017). LF is caused by three parasitic
worms: Wuchereria bancrofti, Brugia malayi, and B. timori, with W. bancrofti causing over 90% of the infections. The major vectors of
W. bancrofti are the Culex, Anopheles, and Aedes mosquitoes. The World Health Organization (WHO) estimates that over 120 million
people are infected with LF in tropical and subtropical areas of the world. Approximately 40 million suﬀer from disabling clinical
manifestations, primarily lymphoedema and elephantiasis, and/or hydrocoele (World Health Organization, 2013). One of the
GPELF's main strategies is to interrupt transmission through mass drug administration (MDA) using three combinations of anthel-
minthic medicines: albendazole plus diethylcarbamazine (DEC); albendazole plus ivermectin (onchocerciasis co-endemic areas), or
the alternative strategy of albendazole twice yearly plus vector control (Loa loa or loiasis co-endemic areas) (World Health
Organization, 2016).
Since the launch of GPELF in 2000, there has been signiﬁcant scale-up of MDA across all regions of the world (World Health
Organization, 2010). However, at the halfway point in 2010 it was highlighted that the WHO's African Region, which accounts for
approximately one third of the global burden of LF, had several challenges and was behind global targets. The main barriers to MDA
implementation included incomplete mapping due to logistical challenges, instability, conﬂict and/or loiasis co-endemicity. The
latter related to the risk of severe adverse events (SAEs), mostly neurological, associated with the use of ivermectin in individuals
with high L. loa microﬁlariae (mf) loads in the blood (Boussinesq, 2006; Gardon et al., 1997; Kelly-Hope et al., 2014; Twum-Danso,
2003). The African Programme for Onchocerciasis Control (APOC), launched in 1995, relied on the community-directed treatment
with ivermectin (CDTI) strategy to control the disease by targeting areas where the prevalence of skin nodules was≥20% determined
by Rapid Epidemiological Mapping of Onchocerciasis (REMO) (Noma et al., 2002). APOC experienced many challenges in expanding
this strategy safely in loiasis areas due to the risk SAEs, and where encephalopathic cases were reported (Twum-Danso, 2003; Zouré
et al., 2014, 2011). The GPELF drew on the APOC experiences to help develop a provisional strategy and practical approach for LF
elimination in the loiasis endemic countries, which take CDTI and vector control coverage into account (Kelly-Hope et al., 2017b;
World Health Organization, 2012).
In Africa, Nigeria has the heaviest LF burden with an estimated 120 million people at risk (Okorie et al., 2013). In 2013, the
Nigerian National LF Elimination Programme planned to scale-up MDA based on recent national mapping results, and the use of
microstratiﬁcation overlap mapping (MOM) to delineate L. loa co-endemicity, CDTI, and insecticide-treated net/long-lasting in-
secticidal mosquito net (ITN/LLIN) distributions to protect from the main Anopheles vectors (Okorie et al., 2013, 2011). Initial
programme work demonstrated successful integration of ITNs with MDA in Central Nigeria (Blackburn et al., 2006; Eigege et al.,
2013), links with the malaria programme and co-implementation strategies (Federal Ministry of Health, 2013) and that community-
wide distribution of LLINs can reduce transmission alone in loiasis co-endemic areas in South East Nigeria (Richards et al., 2013).
However, in some LF-loiasis co-endemic areas more reﬁned mapping and deﬁnition of risk factors were important where there was
uncertainty about the risk of SAEs and if CDTI or alternative intervention strategies should be used. In Nigeria, the CDTI strategy was
adopted in 1997, and currently more than 45 million people are being treated in more than 36,000 communities during the annual
MDA (Federal Ministry of Health, 2017).
In Nigeria, the rapid assessment procedure for loiasis (RAPLOA) helped to deﬁne the distribution throughout the country
(Takougang et al., 2002; Wanji et al., 2005; Zouré et al., 2011). Endemicity was found to be generally low, and closely associated with
southern tropical rain forests that support the main vector, Chrysops spp. habitats (Kelly-Hope et al., 2017a). Understanding LF-loiasis
co-distribution at a micro-level, delineating risk in relation to forested areas and how people move in and around these areas, may
provide insights into where SAEs are more likely to occur, and if the new Test-and-not-Treat (TNT) strategy should be used to help
minimize risk (D'Ambrosio et al., 2015; Kamgno et al., 2016; Pion et al., 2016a). The TNT strategy involves using the LoaScope (a
mobile phone-based video microscope) to rapidly quantify L. loa mf in individuals during MDA, in order to exclude those with high
mf levels and therefore at risk of SAEs. Micro-mapping methods have been used to delineate SAE and environmental risk factors in
onchocerciasis-loiasis and LF-onchocerciasis-loiasis areas within relatively deﬁned geographical parameters (Brito et al., 2017; Kelly-
Hope et al., 2015, 2014; Tekle et al., 2011).
Therefore, to build on these new mapping approaches and better understand factors associated with LF elimination in a loiasis
endemic area, this study aimed to examine the prevalence and co-distribution of the two diseases and the potential demographic,
landscape, and intervention-related risk factors in a co-endemic area in the South West zone of Nigeria. A secondary aim was to
examine the geographical movement and estimated exposure times of individuals infected with loiasis.
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2. Methods
2.1. Study area and site selection
This study was conducted in Osun State in the South West zone of Nigeria (Fig. 1A) where there have been reports of LF (Cano
et al., 2014; Okorie et al., 2013) and loiasis (Adeoye et al., 2008; Ogunba, 1972; Zouré et al., 2011). Osun State is approximately
14,875 km2 in size with a human population of approximately 3.4 million. The state consists of three senatorial districts (i.e. central,
east, west) and is divided into 30 local government areas (LGAs). The economy is mainly based on agriculture and cottage industries.
Osun State has a tropical moist broadleaf forested area, and the climate is tropical with the rainy season occurring between April and
October each year. Photos of a typical forested community with houses made from mud with iron or zinc rooﬁng are shown in Fig. 2.
The northwest region of Osun State was chosen as the study area as it was endemic for both LF and loiasis, and close to the
forested areas which are habitats of Chrysops spp. (Kelly-Hope et al., 2017a). To determine the prevalence and co-distribution of the
two diseases and the potential demographic, landscape, and intervention-related risk factors, a micro-mapping survey was conducted
in 10 communities covering an area approximately 60 km2 over a four-week period in May–June 2014. Communities were selected
using a 15 km grid overlay map, and geo-referenced using the geographical information system (GIS) software (ArcGIS 10, ESRI,
Redlands, CA). This method helped to demarcate a 5 to 15 km distance between each community, ensuring that prevalence was
measured at regular intervals and that a variety of landscape characteristics were incorporated across the study area.
2.2. Sampling and ﬁeld logistics
The survey sample size was based on the WHO guidelines for LF mapping (Gyapong and Remme, 2001; World Health
Organization, 2011a), which includes sampling up to 100 individuals aged> 15 years from each community. Convenience sampling
was used to invite individuals to participate in the survey at a highly-frequented location in the community, which was typically
around the local health centre or chief's house. Only individuals who had lived in the community for ﬁve or more years were included
to better determine if the infections were acquired through local transmission.
Local researchers from the Institute for Advanced Medical Research and Training, University of Ibadan, Osun State NTD staﬀ and
the South West NTD Zonal Coordinator visited each of the 10 communities the week before the study began to inform community
leaders of the survey and sensitize the communities. The team included two research leads, two ﬁeld assistants to help administer the
surveys and two medically trained phlebotomists. When available, the local LGA coordinator assisted with the mobilization of survey
participants. The ﬁeld team was based in the city of Ibadan, and departed early each morning to reach the study communities to
conduct the surveys.
Fig. 1. Nigeria study area LF and loiasis prevalence.
A. Nigeria study area – Osun State
B. LF prevalence
C. Loiasis prevalence
D. LF and loiasis overlapping prevalence
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2.3. LF prevalence
To determine the LF prevalence, rapid diagnosis was carried out using the BinaxNow Filariasis immunochromatographic test
(ICT) cards (Alere Scarborough Inc., ME, USA). From each participant, 100 μl of ﬁnger-prick blood was collected and transferred to
the ICT card to detect the presence of W. bancrofti circulating ﬁlarial antigen (CFA) (World Health Organization, 2011a). The ICT
cards were pre-tested for quality using a positive control, and used per the instructions of the manufacturer. The presence of the W.
bancrofti CFA was recorded for each participant and the percentage of positive individuals was calculated for each community.
Information on LF morbidity was also obtained during the survey. Participants were shown pictures of LF clinical manifestations,
including lymphoedema (limb swelling) and hydroceles (scrotal swelling) and asked if they were suﬀering from any of the symptoms
(World Health Organization, 2013). Participants who indicated they had clinical symptoms were examined and their condition
conﬁrmed by a medical oﬃcer. The number of clinical cases was recorded for each community.
2.4. Loiasis prevalence
To determine the prevalence of L. loa, the RAPLOA survey method was used (Takougang et al., 2002; Wanji et al., 2005; Zouré
et al., 2011) and conducted on the same participants as the LF survey. RAPLOA is a rapid clinical survey method based on the history
of eye worm. Information is obtained from a simple survey relating to an individual's experience of eye worm, which is conﬁrmed by
a photograph showing the L. loa adult worm and the duration of the most recent episode being between 1 and 7 days.
RAPLOA questions include: Have you ever experienced or noticed worms move along the white of your eye? (yes/no); Have you
ever had the condition in this picture? (yes/no); and How long (in days) did the worm stay before disappearing? (between 1 and 7;
yes/no). Loiasis was conﬁrmed when an individual answered positively to all three questions. This is known as the restricted deﬁ-
nition of loiasis, which has been correlated with high L. loa mf rates and risk of SAEs (Addiss et al., 2003). The percentage of
individuals with loiasis was calculated for each community. Those with a prevalence between 20 and 40% were considered at
moderate risk, and those with> 40% at high risk of SAEs.
2.5. Demographic and intervention related risk factors
To identify potential risk factors associated with ﬁlarial prevalence a short semi-structured questionnaire was administered to the
survey participants at the time of the sero-prevalence and clinical assessments. Information on participants' sex (male/female), age
(number), occupation (title), and frequency of visits into the surrounding forested areas (never/daily/weekly/other and reasons) was
collected to determine demographic characteristics that may increase risk of transmission exposure. In addition, information on
participants' usage of interventions was collected and included: the intake of ivermectin for onchocerciasis (yes/no); the number of
times ivermectin had been taken (number); as well as bed net ownership (yes/no) and usage (slept under night before - yes/no).
2.6. Landscape characteristics
To examine the relationship between disease prevalence and the local landscape, particularly forested areas associated with the
risk of loiasis, the communities were categorized per land cover, tree canopy cover and forest canopy height.
Data were obtained from remote sensing sources including the i) GlobCover Land Cover map with 300 m resolution, which was
developed as part of the GlobalCover 2009 Project and provides a detailed portrait of the earth (GlobCover, 2010); ii) Tree cover map
for year 2000, deﬁned as percentage of canopy closure for all vegetation taller than 5 m in height at 500 m resolution (Hansen et al.,
2013); and iii) Forest canopy height, based on a global map of canopy height at 1 km spatial resolution, using 2005 data from space
borne light detection and ranging (lidar) (Simard et al., 2011).These data are among the best high resolution sources available in the
public domain; however, it is acknowledged that there are some limitations with comparisons between layers as the resolution and
time periods vary.
The GPS coordinates of the main location where the surveys were conducted in each community were recorded, i.e. around health
Fig. 2. Photo of study area showing typical houses and nearby forested areas.
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clinic or chief's house. Using the ArcGIS software Geoprocessing (Buﬀer) and Spatial Analyst Tools (Zonal Statistics) (ESRI, Redlands,
CA), a 5 km buﬀer (radius) around this central location was created to account for vectors ﬂight range (Kelly-Hope et al., 2017a).
Related raster data on landscape characteristics were then extracted and summarised to identify the main type of land cover, mean
percentage of tree cover and mean forest canopy height within the community area (Fig. 5A–F), and how they were associated with
LF and loiasis prevalence.
2.7. Loiasis case tracking – GPS data logger pilot study
To begin to understand how human movement in and around forested areas may inﬂuence the risk of loiasis, the use of GPS data
loggers (I-gotU GT-120, Mobile Action, UK) was piloted by recording and mapping the movement of participants with loiasis. In total,
20 participants with loiasis were randomly selected and invited to wear a GPS data logger over a period of 4 days. One participant
without loiasis per community was also selected as a control for comparison; however, for this pilot they were not matched by age,
sex or occupation. The ﬁeld methods followed those used in another study (Seto et al., 2012). Brieﬂy, the data loggers were pro-
grammed to record the participant's location at ﬁve-minute intervals for the four-day study period. The device was attached to a
Velcro wristband and participants were instructed to wear it during all times that they were awake (Fig. 4A–B). The data logger
information was downloaded to a computer and converted into GPX ﬁles. The average speed and distance travelled by each parti-
cipant was recorded and the geographic-speciﬁc data mapped on Google™ earth and using ArcGIS 10 (ESRI, Redlands, CA).
2.8. LF entomological – Preliminary work
To better understand the potential LF mosquito vectors in the study area, a small entomological follow-up survey was conducted
between July and September 2014 in the three ICT positive communities of Ekuro, Ogburo and Ado Ori Oke, which are in diﬀerent
locations with varying prevalences and landscape characteristics (Table 1).
Adult mosquitoes were collected using CDC light traps and Pyrethrum Spray Catch (PSC) in 23 to 26 selected houses of each
community over a three-night period. The number of houses sampled depended on the number of houses whose occupants consented
to the study. CDC light traps were set up indoors between 18.00 and 06.00 h in selected houses and placed close to the feet of a person
sleeping under a bed net at a height of 150 cm. The PSCs were conducted between 06.00 and 08.00 h. Prior to the collection, all food,
animals and small furniture were removed from the room. All mosquitoes knocked down were collected with forceps, placed in a
labelled petri-dish on a layer of damp cotton wool and ﬁlter paper, and kept in labelled paper cups for identiﬁcation and further
analysis in the laboratory.
Mosquitoes were ﬁrst identiﬁed to Genus level using morphological keys and placed in labelled eppendorf tubes containing
drierite for further processing. Species identiﬁcation and detection of W. bancrofti DNA in mosquitoes was then conducted. DNA was
extracted from the mosquitoes using the Qiagen DNeasy tissue kit (QiagenDNeasy® kit; Mississauga, Canada). Culex mosquitoes were
grouped into 5 pools of 20 mosquitoes per pool. Anopheles mosquitoes were analysed individually. Anopheles mosquitoes were
identiﬁed by PCR (Scott et al., 1993). Identiﬁcation of W. bancrofti parasite DNA in the mosquitoes was also conducted by PCR
(Ramzy et al., 1997; Weil and Ramzy, 2007).
2.9. Data management and statistical analysis
Survey data were recorded on pre-printed forms in the ﬁeld and entered onto Microsoft Excel™ 2010. Data were analysed using
Excel™ and IBM Statistical Package for the Social Sciences (SPSS) (version 24) (SPSS Inc., Chicago, IL, USA). Participant responses
were grouped into categorical variables based on frequency of the responses to survey questions. Analysis was conducted using the
Fisher's exact test, with P-values generated to determine diﬀerences between the variables. A P-value of ≤0.05 was considered
Table 1
Summary of each study community, location and landscape characteristics.
LGA Community Longitude Latitude Land cover class (majority) Tree coverage (mean -
%)
Forest canopy height
(mean - m)
Ayedire Ile Iran 7.6038 4.1879 Mosaic vegetation/croplands 22.1% 9.1
Kuta Ileogbo Railway
Station
7.5984 4.2803 Broadleaved evergreen or semi-
deciduous forest
35.6% 13.2
Ede South Gaagaa 7.6554 4.4855 Broadleaved evergreen or semi-
deciduous forest
45.7% 16.7
Ogobi Oja 7.6659 4.4347 Broadleaved evergreen or semi-
deciduous forest
33.1% 10.0
Egbedore Aba bale 7.8080 4.3952 Open broadleaved deciduous forest 35.6% 13.1
Ekuro 7.7302 4.3640 Open broadleaved deciduous forest 27.5% 9.5
Ejigbo Ado-ori Oke 7.8254 4.2652 Open broadleaved deciduous forest 29.9% 6.5
Agurodo 7.9443 4.2700 Closed to open shrub land 19.4% 2.5
Inisa Edoro 7.8036 4.2806 Open broadleaved deciduous forest 34.5% 9.1
Iwo Ogburo 7.5969 4.1063 Mosaic vegetation/croplands 32.8% 13.1
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statistically signiﬁcant.
2.10. Ethics, consent and patient referrals
Ethical approval was granted by the Research Ethics Committee, Liverpool School of Tropical Medicine, UK, as well as by the
University of Ibadan/University College Hospital (UI/UCH) Ethics Review Committee and the Osun State Ministry of Health, Nigeria.
Participants were informed about the purpose of the study in Yoruba and English, and requested to give written consent indicating
their willingness to participate in the study. Participants found to be positive for LF and loiasis were informed of preventive measures
and referred to the local health clinic. The community leaders, local clinics, and state Ministry of Health were informed of the survey
results to help facilitate care and treatment in each of the communities, and to raise awareness of the risk associated with both ﬁlarial
infections.
3. Results
The survey was conducted across the 10 selected communities from 5 LGAs including Ile Iran and Kuta Ileogbo Railway Station
(Ayedire LGA); Gaagaa and Ogobi Oja (Ede South LGA); Aba bale and Ekuro (Egbedore LGA); Ado-ori Oke, Agurodo and Inisa Edoro
(Ejigbo LGA) and Ogburo (Iwo LGA). The LGAs, communities, geographic coordinates of the central location where the surveys were
conducted and the landscape characteristics are summarised in Table 1.
A total of 870 participants were included in the survey, ranging from 74 to 96 participants per community. It was not possible to
Table 2
Summary of LF and loiasis prevalence and risk factors.
Variable Total LF Loiasis
+ve (%) P value +ve Loa (%) P value
Demographic characteristics
LGA Ayedire 169 4 2.4% 6 3.6%
Ede South 174 0 0 19 10.9%
Egbedore 179 3 1.7% 12 6.7%
Ejigbo 274 7 2.6% 20 7.3%
Iwo 74 1 1.4% 0.321 1 1.4% 0.023*
Community Ile Iran 83 1 1.2% 3 3.6%
Kuta Ileogbo Railway 86 3 3.5% 3 3.5%
Gaagaa 85 0 0 9 10.6%
Ogobi Oja 89 0 0 10 11.2%
Aba bale 88 0 0 7 8.0%
Ekuro 91 3 3.3% 5 5.5%
Ado-ori Oke 85 4 4.7% 5 5.9%
Agurodo 96 2 2.1% 10 10.4%
Inisa Edoro 93 1 1.1% 5 5.4%
Ogburo 74 1 1.4% 0.178 1 1.4% 0.121
Sex Male 349 11 3.2% 18 5.2%
Female 521 4 0.8% 0.014* 40 7.7% 0.166
Age group 15–50 409 7 1.7% 21 5.1%
51–100 460 8 1.7% 37 8.0%
No answer 1 0 0 1.0 0 0 0.162
Occupation Farmer 354 8 2.3% 19 5.4%
Trader 256 1 0.4% 18 7.0%
Farmer/trader/other 73 1 1.4% 7 9.6%
Student 80 2 3.8% 5 6.3%
Other 107 3 1.9% 0.234 9 8.4% 0.638
Forest visits Never 82 1 1.2% 5 6.1%
Daily 496 7 1.4% 28 5.6%
Weekly/monthly 292 7 2.4% 0.63 25 8.6% 0.301
Intervention history
Ivermectin Never 253 6 2.4% 13 5.1%
1–4 rounds 437 7 1.6% 32 7.3%
5+ rounds 145 2 1.4% 13 9.0%
Does not know 35 0 0 0.776 0 0 0.207
Bed net own Yes 745 10 1.3% 53 7.1%
No 125 5 4.0% 0.051* 5 4.0% 0.246
Bed net sleep Yes 502 5 1.0% 34 7.8%
No 243 5 2.1% 19 6.8%
Does not own 125 5 4.0% 0.058 5 4.0% 0.382
Total 15 1.7% 58 6.7%
* Denotes statistically signiﬁcant diﬀerence with P value≤ 0.05.
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attain the target 100 participants per community who had lived in the community for 5 years or more during the study period
because some communities were small, disbanded and/or the adults were working away from home. In total, there were 349 males
(40.1%) and 521 females (59.9%) included in the survey. The mean age was 49.9 years (range 15 to 100 years), which was similar for
males (49.0 years) and females (50.5 years).
3.1. LF prevalence, risk factors and entomology
Overall, LF prevalence was low with only 15 participants (1.7%; n = 870) found to be ICT positive. No participant reported they
had lymphoedema, but one male reported he had a hydrocele (aged 62 years, Agurodo community). Another reported he had an
operation to remove a hydrocele three years prior (aged 50 years, Gaagaa). A summary of LF prevalence by demographic char-
acteristics is presented in Table 2.
3.1.1. Demographic characteristics
The prevalence varied across the LGAs and communities, as shown in Fig. 1B. The LGAs with the highest prevalence were Ayedire
and Ejigbo and included the communities of Ado-ori Oke (4.7%; n = 85) and Kuta Ileogbo Railway Station (3.5%; n = 86). The
communities of Gaagaa and Ogobi Oja in Ede South LGA and community of Aba bale in Egedbore LGA reported no positive cases (in
contrast, these three communities were found to have among the highest loiasis prevalence – see next section).
Males were found to have signiﬁcantly higher LF prevalence than females (3.2% vs 0.8%; P = 0.014) (Table 2). There was no
diﬀerence found between participants aged below or above the mean age of 49.9 years, and no distinct pattern across the diﬀerent
Fig. 3. LF and loiasis number of positive cases and prevalence by age group and sex.
A. LF positive numbers
B. Loiasis positive numbers
C. LF prevalence
D. Loiasis prevalence
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decadal age groups; however, no female participants aged between 20 and 60 years were found to be ICT positive as shown in Fig. 3A
& C.
The most common occupational groups were farmers (40.7%; n = 354), traders (29.4%; n = 256), combination of farmer/
trader/other work, as well as students (9.2%; n = 8) and other groups, which included trades such as carpenters, tailors, and
professional groups such as teachers, doctors, and pastors. Of the occupational groups, farmers (2.3%; n = 354) and students (3.8%;
n = 8) were found to have the highest LF prevalence, while traders had the lowest (0.4%; n = 256).
The frequency in which participants visited forested areas varied with nearly 10% stating that they never did, while more than
half visited on a daily basis (57.0%; n = 496). One third visited less frequently on a weekly, monthly, or seasonal basis (33.6%;
n = 292) mainly to farm, which included harvesting palm nut and making palm nut oil. There was no signiﬁcant diﬀerence in LF
prevalence between participants who stated they visit the forest at least one time per month versus those who stated they never visit
the forest.
3.1.2. Intervention history
Overall, approximately one third of participants (29.1%; n = 870) stated they had never taken ivermectin for onchocerciasis, and
of these, 6 participants were ICT positive (2.4% prevalence) (Table 2). This compares to the 437 participants (50.2%) who had taken
1–4 rounds with 7 ICT positive participants (1.6% prevalence), and the 145 participants (16.7%) who had≥5 rounds of ivermectin
with 2 ICT positive participants (1.4% prevalence). A small proportion (4%) did not know if they had taken the drug, and were all ICT
negative. No signiﬁcant diﬀerences were found between the ivermectin groups.
Overall, most participants stated they owned a bed net (85.6%; n = 870) and had a signiﬁcantly lower prevalence (1.3%)
compared to those who did not own a bed net (4.0% prevalence) (P = 0.051) (Table 2). A signiﬁcantly higher proportion of females
(92.3%) stated that they owned a bed net compared with males (75.5%) (P = 0.000).
Of those who owned a bed net, when asked if they slept under it the night before, two thirds of participants stated they had
(67.4%; n = 745) and were found to have a lower LF prevalence (1.0%) than those 243 participants who did not (2.1%), as well as to
those 125 participants who did not own a net at all (4.0%). The diﬀerence in LF prevalence between the bed net groups was
approaching statistical signiﬁcance (P = 0.058).
3.1.3. Landscape characteristics
The most dominant type of land cover for each community (5 km radius) included mosaic vegetation/croplands, closed to open
shrub land, closed to open broadleaved evergreen/or semi-deciduous forest and open broadleaved deciduous forest (Table 1). No
signiﬁcant diﬀerence in LF prevalence was found between the main classiﬁcations as shown in Table 3.
The mean percentage of tree coverage ranged from 19.4% to 45.7% (overall mean 32.5%; Table 1), and when comparing the LF
prevalence above/below the mean, communities with less than average tree coverage were found to have a higher LF prevalence
(2.8%) than those with above average tree coverage (1.0%) with diﬀerences approaching statistical signiﬁcance (P = 0.060)
(Table 3).
The mean forest canopy height ranged from 2.5 m to 16.7 m (overall mean 10.3 m; Table 1), and when comparing the LF
prevalence above/below the mean, communities with less than average forest canopy height were found to have a higher LF pre-
valence (2.5%) than those with above average canopy height (0.9%), which were not found to be signiﬁcant diﬀerent (Table 3).
Fig. 4. GPS logger on participant arm.
A. GPS logger
B. GPS logger strapped to arm to track travel
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3.1.4. Entomological study
A total of 157 mosquitoes comprising of Anopheles (64.3%), Culex (35.0%) and Aedes (0.6%) were collected using both PSC and
CDC light traps (Table 4). Out of the 101 Anopheles mosquitoes collected, 98 (97.0%) were identiﬁed as Anopheles gambiae while 3
(2.9%) were identiﬁed as Anopheles arabiensis. Only 1 An. gambiae mosquito was positive for W. bancrofti DNA (Table 5).
3.2. Loiasis prevalence, risk factors and data logger maps
Overall, loiasis prevalence determined by RAPLOA was 6.7% with 58 participants answering yes to all three RAPLOA questions.
In total, 149 participants (17.1%) stated they had experienced a worm moving in their eye (question 1). Of those participants, 79
Fig. 5. Landscape characteristics by study sites (5 km buﬀer).
A. Land cover
B. Land cover type – site 5 km radius
C. Tree canopy coverage
D. Canopy coverage – site 5 km radius
E. Tree canopy height
F. Canopy height – site 5 km radius
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conﬁrmed the worm with the picture provided (question 2) and of those, 58 stated that the worm was in their eye for 1 to 7 days
(question 3). A summary of prevalence by demographic characteristics, intervention history and landscape characteristics is shown in
Table 2.
3.2.1. Demographic characteristics
The loiasis prevalence varied across the LGAs and communities as shown in Fig. 1C. Overall, signiﬁcant diﬀerences were found
between the diﬀerent LGAs (P = 0.023) (Table 2). The LGAs with the highest loiasis prevalence were Ede South (10.9%) and Ejigbo
Fig. 6. GPS data logger loiasis case and control patterns for the study area and six communities.
A. Overall patterns of data loggers
B. Ogburo (loiasis 1.4%)
C. Ile Iran (3.6%)
D. Agurodo (10.4%)
E. Aba bale (8.2%)
F. Ogobi Oja (11.2%)
G. Gaagaa (10.6%)
Table 3
Summary of LF and loiasis prevalence and intervention and landscape characteristics.
Variable Total LF Loiasis
Landscape characteristics
Land cover Mosaic vegetation - cropland 157 2 1.3% 4 2.5%
Shrub land 96 2 2.1% 10 10.4%
Deciduous forest 357 8 2.2% 22 6.2%
Evergreen/semi-deciduous forest 260 3 1.2% 0.756 22 8.5% 0.046*
Tree coverage (%) < 33% of total area 355 10 2.8% 23 6.5%
> 33% of total area 515 5 1.0% 0.060 35 6.8% 0.891
Forest canopy height (mean) < 10 m of total area 448 11 2.5% 28 6.3%
> 10 m of total area 422 4 0.9% 0.118 30 7.1% 0.684
Total 15 1.7% – 58 6.7%
Table 4
Number and mosquito species compositions collected by diﬀerent collection methods.
Community Pyrethroid spray catch (PSC) CDC light trap
Anopheles Culex Aedes Total Anopheles Culex Aedes Total
Ekuro 37 1 0 38 7 0 0 7
Ogburo 26 0 1 27 30 0 0 30
Ado-ori Oke 1 34 0 35 0 20 0 20
Total 64 35 1 100 37 20 0 57
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(7.3%) and included the high prevalence communities of Ogobi Oja (11.2%), Gaagaa (10.6%), and Agurodo (10.4%). The lowest was
in Iwo LGA, Ogburo community (1.4%) and in Ayedire LGA, in Ile Iran (3.6%), and Kuta Ileogbo Railway Station (3.5%) commu-
nities. Overall, there appeared to be small geographical diﬀerences between loiasis and LF prevalence patterns, with higher loiasis
communities in the eastern part of the study area and higher LF communities in the western region of the study areas as highlighted
in Fig. 1D–E. Further, only one participant was found to be both loiasis and ICT positive. The participant was a 64 year old female
from Ado-ori Oke community, who had lived in the community for 37 years, visited the forest weekly to farm, reported to have only
taken ivermectin twice and did not own a bet net.
Females (40/521; 7.7%) were found to have higher numbers of positive loiasis cases and prevalence than males (18/349; 5.2%);
however, the diﬀerences were not signiﬁcant (Table 2). There was also no diﬀerence found between participants aged below or above
the mean age of 49.9 years, however there was a small increasing trend with age for both females and males from the 30–39 year age
group onwards as shown in Fig. 3B and D.
Loiasis prevalence was found not to vary signiﬁcantly between the diﬀerent occupational groups, with the farmers/trader/other
group (9.6%) reporting the highest, and farmers the lowest (5.3%). Similarly, there was no distinct pattern in prevalence between the
forest visit groups (Table 2).
3.2.2. Intervention history
Of those who had never taken ivermectin for onchocerciasis (n = 253), 13 were loiasis positive (5.1% prevalence), which was not
signiﬁcantly diﬀerent to those who had taken 1–4 rounds (7.3% prevalence), and those who had ≥5 rounds of ivermectin (9.0%
prevalence).
Similarly, no signiﬁcant diﬀerences were found between the prevalence of those who owned a bed net (7.1% n = 745) and those
who did not (4.0%; n = 125), or those participants who slept under the bed net the night before (7.8%; n = 502) and those who did
not (6.8%; n = 243) (Table 2).
3.2.3. Landscape characteristics
There was a signiﬁcant diﬀerence in loiasis prevalence between the four main classiﬁcation groups of mosaic vegetation/crop-
lands (2.5%), shrub land (10.4%), deciduous forest (6.3%) and evergreen/semi-deciduous forest (8.5%), but not when comparing the
loiasis prevalence above/below the mean tree coverage or forest canopy height as shown in Table 3.
3.2.4. Loiasis GPS data logger pilot study
In total, eight loiasis positive participants and eight control participants were included in the GPS data logger analysis, as data
from Ado-ori Oke and Inisa Edoro were not used due to devices not recording correctly. For loiasis positive participants, there were
four males and four females, with an average age of 55 years and main occupations reported as farmer, trader and pastor. For the
control participants, there were six males and two females, with an average age of 52 years and main occupations reported as farmer,
trader, pastor and nurse. The participants travelled by foot as well as local transport including cars and motorcycles. All movement
was included in the analysis.
Fig. 6A shows the locations where the 16 participants worked or travelled over the 4 days, highlighting the wide area covered by
both groups. Overall, the average speed (km/h), and distance (km) were similar for the loiasis positive (9.1 km/h and 17.4 km), and
control (10.2 km/h and 15.2 km) participants. There were similar trends in the speed and distance among the males (loiasis 7.9 km/
h; 15.4 km and control 10.8 km/h; 14.9 km) and females (loiasis 10.3 km/h; 19.5 km and control 7.7 km/h; 16.7 km).
To better understand the environment in which people move around within the study area, a close-up examination of the loiasis
positive cases and controls from six communities across diﬀerent levels of loiasis prevalence and landscapes were visualised using
Google Earth (Fig. 6B-G). These images highlight the denser forested areas within the higher loiasis risk communities of Aba bale,
Ogobi Oja and Gaagaa. It also highlights the sparser land cover in the lower loiasis risk communities of Ogburo and Ile Iran, where the
land cover was predominately mosaic vegetation/croplands with less tree canopy coverage and forest height than the other com-
munities. The GPS data show that loiasis positive participants in Ogburo, Aba bale, Ogobi Oja and Gaagaa were in the forested areas
more frequently than the controls; however, the sample size in this pilot study is too small to make any inference.
4. Discussion
This is the ﬁrst survey in Osun State, Nigeria to determine the presence of two ﬁlarial infections based on a combination of WHO
Table 5
Anopheles mosquito identiﬁcation and W. bancrofti detection.
An. gambiae An. arabiensis Culex sp
Community No. analysed No. positive (%) No. analysed No. positive (%) No. analysed No. positive (%)
Ekuro 44 1 (2.3) 0 0 37 0
Ogburo 54 0 2 0 26 0
Ado-ori Oke 0 0 1 0 37 0
Total 98 1 (1.0) 3 0 100 0
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LF mapping and RAPLOA survey methods (World Health Organization, 2011a; Zouré et al., 2011). The micro-mapping approach used
helped to delineate risk a ﬁne scale and could help to direct targeted standard or alternative intervention strategies. The ﬁndings
highlight the variation in LF and loiasis prevalence and how their distributions diﬀer to each other within a relatively deﬁned
geographical area. Higher LF prevalences were predominately found in communities with low loiasis prevalence, and vice versa, and
only one participant was found to have evidence of both infections. This supports ﬁndings from other studies highlighting the general
low prevalence of W. bancrofti in L. loa areas, and that there is a general disparate or competitive exclusive relationship between
diﬀerent ﬁlarial parasitic infections, with little evidence of co-morbidity (Hawking, 1974; Molyneux et al., 2014). The landscape
characteristics also appear to diﬀer for each infection.
Overall, LF prevalence was low, with few participants found to be antigen positive and presumably infected or having evidence of
clinical conditions. This is key information for the LF programme as the low endemicity suggests that transmission may be readily
interrupted. Further, the environmental associations may help to identify risk areas, understand vector ecological habitats and target
the most appropriate intervention strategy. An absence of W. bancrofti transmission was found in the more densely forested com-
munities where loiasis was more prevalent, which may be due to some form of parasite competition as noted above, or alternatively,
related to the local Anopheles vectors that may not thrive in such shaded canopied areas. Higher W. bancrofti transmission was
associated with open and less vegetative landscapes, which may better suit the breeding habitats of the local vectors, including An.
gambiae (Wiebe et al., 2017). Follow-up testing for nocturnal W. bancrofti mf in night blood samples was not conducted as it was out
of the scope of the study, and because travelling late at night was considered to be diﬃcult and dangerous. This is acknowledged as a
limitation of the study, especially given the potential problem of ICT cross-reactivity leading to false positive results in very high-risk
L. loa co-endemic areas, which was not published at the time of the study (Bakajika et al., 2014). However, given that the study area
was situated on the fringe of a low loiasis endemic area, the ICT was considered still to be a valid tool (Pion et al., 2016b).
Further entomological work in this area will help to determine the extent of LF transmission in local Anopheles species (Okorie
et al., 2011), and the impact of bed nets as an additional intervention strategy as recommended by the WHO in LF-loiasis co-endemic
areas (Kelly-Hope et al., 2017b; World Health Organization, 2012). It may also help to determine if xenomonitoring has a role in
delineating risk and endgame surveillance in GPELF (Pedersen et al., 2009). Bed net ownership and usage were associated with lower
LF prevalence, suggesting they are an eﬀective vector control tool, as shown in other studies (Nsakashalo-Senkwe et al., 2017;
Rebollo et al., 2015; van den Berg et al., 2013; Richards et al., 2013). However, the LF programme could optimise this impact further
by increasing coverage among the male population, as they had a higher prevalence and were less likely than their female coun-
terparts to own a bed net. Understanding the reasons why males have a high risk of LF in this particular area of Nigeria is important.
The reason may be related to work or leisure activities, or time spent sleeping outside in bush/forested areas as shown elsewhere, or
related to inﬂuence of social support (Chesnais et al., 2014; Russell et al., 2015). It may also be related to the use of interventions
because males are not targeted by malaria bed net campaigns, which primarily focus on pregnant women and children (although
house to house distribution is carried out where possible) (Federal Ministry of Health, 2013). It is foreseeable that the scale-up of
universal bed net coverage for malaria may lead to a wider reduction in LF transmission in the future (Kimura, 2011). To help
monitor this, it will be essential to continue with strong collaborative links between the malaria and LF programmes (Blackburn et al.,
2006; Federal Ministry of Health, 2013; Kelly-Hope et al., 2013; Molyneux and Nantulya, 2004; World Health Organization, 2011b).
Key collaborative links between the onchocerciasis and LF programmes will also be important, as well as coordination with the new
Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) (Hopkins, 2016; World Health Organization, 2015).
The additional information collected on ivermectin MDA for onchocerciasis through the CDTI platform provided some insights
into drug coverage and potential areas to improve. This is important for the onchocerciasis elimination plan for Osun State, which
overall is making good progress (Federal Ministry of Health, 2017). Interestingly, there was lower LF prevalence among those who
had participated in more MDA rounds, suggesting that CDTI may have some impact (Kyelem et al., 2003). However, of particular
note, was that approximately one third of participants reported that they had never or could not recall taking ivermectin, and around
half reported they had taken ivermectin in less than ﬁve MDA rounds. Notwithstanding the limitation of recall bias, the seemingly
low MDA coverage highlights the need for the LF programme to implement high levels of advocacy and social mobilization to help
ensure adequate coverage and impact. This is particularly important in LF-loiasis co-endemic areas where ivermectin MDA has
already been implemented, and could help the onchocerciasis elimination programme. The LF programme is recommended to build
on this community distribution platform; however, understanding the CDTI duration and coverage, both therapeutic and geo-
graphical, is essential to ensure safety as there could still be the risk of SAEs in untreated areas (Kelly-Hope et al., 2017b).
Overall, the loiasis prevalence was low, and within the expected range on the fringe of the meso-endemic area (Zouré et al.,
2011). This suggests a limited risk of SAEs. However, identifying any potential hotspots and sub-groups at risk will be essential before
the expansion of ivermectin MDA for LF elimination. The highest loiasis prevalence was found in Ede South LGA and communities
herein may require more SAE vigilance than other LGAs. Higher transmission was also associated with forested landscapes with
greater tree coverage and higher canopies, which better suit the breeding habitats of the main L. loa vector, Chrysops spp. (Kelly-Hope
et al., 2017a). Population growth and land-use change has been associated with a decline in L. loa transmission. This was also
supported by the land cover maps and satellite images, which highlight the landscape diﬀerences between high and low loiasis risk
areas. It is important to note that there were some limitations with the environmental data used, as they varied in resolution and the
time period covered. This was most notable with the 2000 tree cover map used for the study period; however, modelled high
resolution maps indicated minimal forest cover change in the area between 2000 and 2016 (Hansen et al., 2013).
The use of modelled environmental data and satellite imagery provides new ways to understand ecological drivers of trans-
mission, and if conducted on a larger scale, may help to further delineate risk, and implement the safest LF treatment strategy in
loiasis co-endemic areas (Cano et al., 2014). Similarly, the Loa Antibody Rapid Test, a new rapid diagnostic test for detecting
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exposure to L. loa, may be used in the future to reﬁne prevalence maps so that elimination programs can target intervention strategies
and reduce the risk of SAEs (Pedram et al., 2017). The additional use of GPS data loggers as a novel approach to mapping geo-
graphical patterns may also help to highlight risk areas on a micro-level. Participants were willing to wear tracking devices and these
could be further used to identify and map Chrysops spp. breeding sites for targeted vector control and thus transmission suppression
(Kelly-Hope et al., 2017a; Seto et al., 2012). The pilot study found that loiasis positive cases and controls moved at similar speeds and
distances overall; however, extending this study over a longer period, and including non-forested communities may lead to a better
understanding of exposure times and locations associated with high loiasis prevalence.
This study provides key information to the Osun State LF programme on the risk and strategies for LF elimination in loiasis co-
endemic areas. It highlights that the overall low transmission may be readily impacted if the CDTI platform is expanded to include
albendazole, and eﬀorts to expand bed net coverage and use are continued. The new integrated survey approach was useful to
determine the extent of co-endemicity and high risk areas, and will help initiate measures to limit the occurrence or impact of SAEs. It
may be that the Test-and-not-Treat strategy can be used in some high risk loiasis communities (D'Ambrosio et al., 2015). These areas
can be delineated by forested landscape characteristics and mapping methods and extrapolated across the state to ensure safety and
impact.
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